Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11343444
[patent_doc_number] => 09527839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Benzimidazole tetrahydropyran derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/420090
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41479
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420090
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420090 | Benzimidazole tetrahydropyran derivatives | Aug 14, 2013 | Issued |
Array
(
[id] => 10340416
[patent_doc_number] => 20150225421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMPOUND AND PHARMACEUTICAL COMPOSITION FOR NEUROPSYCHOLOGICAL DISORDER OR MALIGNANT TUMOR'
[patent_app_type] => utility
[patent_app_number] => 14/418342
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24777
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418342
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418342 | Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor | Jul 29, 2013 | Issued |
Array
(
[id] => 9427883
[patent_doc_number] => 08703960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Benzobisthiazole building blocks for conjugated polymers'
[patent_app_type] => utility
[patent_app_number] => 13/950720
[patent_app_country] => US
[patent_app_date] => 2013-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 3404
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950720
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/950720 | Benzobisthiazole building blocks for conjugated polymers | Jul 24, 2013 | Issued |
Array
(
[id] => 9281592
[patent_doc_number] => 20140031560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'PROCESS FOR THE PREPARATION OF BENDAMUSTINE'
[patent_app_type] => utility
[patent_app_number] => 13/948182
[patent_app_country] => US
[patent_app_date] => 2013-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13948182
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/948182 | Process for the preparation of bendamustine | Jul 22, 2013 | Issued |
Array
(
[id] => 9198843
[patent_doc_number] => 20130338158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => '6-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID AMIDE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONIST BIOLOGICAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/946564
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44126
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946564
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/946564 | 6-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID AMIDE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONIST BIOLOGICAL ACTIVITY | Jul 18, 2013 | Abandoned |
Array
(
[id] => 9149044
[patent_doc_number] => 20130303567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'SMALL MOLECULE INHIBITORS OF PARP ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/941510
[patent_app_country] => US
[patent_app_date] => 2013-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24864
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941510
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/941510 | SMALL MOLECULE INHIBITORS OF PARP ACTIVITY | Jul 13, 2013 | Abandoned |
Array
(
[id] => 10322079
[patent_doc_number] => 20150207083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/413736
[patent_app_country] => US
[patent_app_date] => 2013-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19395
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413736
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/413736 | Benzimidazo[1,2-A]benzimidazole derivatives for electronic applications | Jul 7, 2013 | Issued |
Array
(
[id] => 10406565
[patent_doc_number] => 20150291574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'NOVEL POLYMORPHS OF AZILSARTAN'
[patent_app_type] => utility
[patent_app_number] => 14/589575
[patent_app_country] => US
[patent_app_date] => 2013-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3005
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589575 | NOVEL POLYMORPHS OF AZILSARTAN | Jul 7, 2013 | Abandoned |
Array
(
[id] => 9122145
[patent_doc_number] => 20130289067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'COMPOUNDS AND METHODS FOR TREATING HIV'
[patent_app_type] => utility
[patent_app_number] => 13/929395
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46537
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/929395 | Compunds and methods for treating HIV | Jun 26, 2013 | Issued |
Array
(
[id] => 9120867
[patent_doc_number] => 20130287789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/927514
[patent_app_country] => US
[patent_app_date] => 2013-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52685
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13927514
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/927514 | Organic compounds | Jun 25, 2013 | Issued |
Array
(
[id] => 10483213
[patent_doc_number] => 20150368233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 14/388218
[patent_app_country] => US
[patent_app_date] => 2013-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6223
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388218
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388218 | Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient | Jun 23, 2013 | Issued |
Array
(
[id] => 10805177
[patent_doc_number] => 20160151334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'SUBSTANCE HAVING TYROSINE KINASE INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/900473
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9916
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900473
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/900473 | Substance having tyrosine kinase inhibitory activity and preparation method and use thereof | Jun 19, 2013 | Issued |
Array
(
[id] => 9263317
[patent_doc_number] => 20130345246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => '2H-Imidazol-4-Amine Compounds and Their Use as Bace Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/916690
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26443
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916690
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916690 | 2H-imidazol-4-amine compounds and their use as BACE inhibitors | Jun 12, 2013 | Issued |
Array
(
[id] => 9263319
[patent_doc_number] => 20130345248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Cyclohexane-1,2\'-Naphthalene-1\',2\"-Imidazol Compounds and Their Use as Bace'
[patent_app_type] => utility
[patent_app_number] => 13/916731
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15751
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916731 | Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors | Jun 12, 2013 | Issued |
Array
(
[id] => 9263343
[patent_doc_number] => 20130345272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Cycloalkyl Ether Compounds and Their Use as Bace Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/916740
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18374
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916740 | Cycloalkyl ether compounds and their use as BACE inhibitors | Jun 12, 2013 | Issued |
Array
(
[id] => 9263318
[patent_doc_number] => 20130345247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Cyclohexane-1,2\'-Indene-1\',2\"-Imidazol Compounds and Their Use as Bace Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/916701
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16556
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916701
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916701 | Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitors | Jun 12, 2013 | Issued |
Array
(
[id] => 9094993
[patent_doc_number] => 20130274304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Chemical Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/915674
[patent_app_country] => US
[patent_app_date] => 2013-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25662
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13915674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/915674 | Chemical compounds | Jun 11, 2013 | Issued |
Array
(
[id] => 9518229
[patent_doc_number] => 20140154716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/913919
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 74319
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913919
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913919 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | Jun 9, 2013 | Abandoned |
Array
(
[id] => 10267066
[patent_doc_number] => 20150152063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'INDAZOLE GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/403779
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28804
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403779
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403779 | Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | Jun 6, 2013 | Issued |
Array
(
[id] => 10281531
[patent_doc_number] => 20150166527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'BENZIMIDAZOLE-PROLINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/405649
[patent_app_country] => US
[patent_app_date] => 2013-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86924
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405649
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/405649 | Benzimidazole-proline derivatives | Jun 2, 2013 | Issued |